GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.05.21	CureVac Says CV2CoV Showed High Immunogenicity Against Virus Variants In Preclinical Study (RTTNews)
28.04.21	GlaxoSmithKline Q1 Adj. Operating Profit Declines, Turnover Down 15% CER; Reconfirms 2021 Guidance (RTTNews)
22.04.21	FDA Approves GSK's BLA For Jemperli In Treatment Of Endometrial Cancer (RTTNews)
21.04.21	Hikma Resumes Launch Of Generic Version Of GlaxoSmithKline's Advair Diskus In U.S. (RTTNews)
12.04.21	Zentalis Enters Clinical Collaboration And Supply Agreement With GSK To Evaluate ZN-c3 (RTTNews)
30.03.21	GlaxoSmithKline Announces Changes In Reporting Of Respiratory And HIV Categories - Quick Facts (RTTNews)
29.03.21	Lilly, Vir And GSK Announce Positive Data From Phase 2 BLAZE-4 Trial On COVID-19 (RTTNews)
26.03.21	GlaxoSmithKline, Vir Submit EUA Request To FDA For VIR-7831 - Quick Facts (RTTNews)
16.03.21	Medicago, GSK Begin Phase 3 Trial Of Plant-derived COVID-19 Vaccine Candidate - Quick Facts (RTTNews)
11.03.21	Hikma Pharma, GSK To Cease Potential Acquisition (RTTNews)
11.03.21	Vir, GSK : VIR-7831 Reduces Hospitalization And Risk Of Death In Early Treatment Of COVID-19 (RTTNews)
04.03.21	KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent (RTTNews)
03.03.21	Stock Alert: Vir Biotechnology Closes Enrollment In COVID-19 Vaccine Trial (RTTNews)
25.02.21	GSK : Phase 2 Trial Of Otilimab In Hospitalized COVID-19 Patients Did Not Reach Significance (RTTNews)
22.02.21	Sanofi, GSK To Refine Antigen Formulation Of COVID-19 Vaccine Based On Initial Phase 1/2 Study (RTTNews)
17.02.21	GlaxoSmithKline, Vir Expand Collaboration To Include Respiratory Viruses (RTTNews)
11.02.21	Novartis' Sandoz To Buy GSK's Cephalosporin Antibiotics Business - Quick Facts (RTTNews)
05.02.21	CureVac, UK To Collaborate On Development Of Vaccines Against SARS-CoV-2 Variants (RTTNews)
03.02.21	GlaxoSmithKline FY20 Adj. Operating Profit Up 2% At CER On Turnover Increase Of 3% (RTTNews)
03.02.21	GSK, CureVac To Develop MRNA COVID-19 Vaccines (RTTNews)
02.02.21	ADMS Gets FDA Nod, ARQT Soars On Psoriasis Trial Data, DVAX Catches Eye, PRTA On Watch (RTTNews)
28.01.21	AGTC Sheds Light On Achromatopsia Trials, LLY, VIR And GSK Team Up, CVM Turns Head As It Awaits Data (RTTNews)
27.01.21	Lilly, Vir Biotechnology, GSK Say First Patient Dosed In Expanded BLAZE-4 Trial - Quick Facts (RTTNews)
26.01.21	Hikma Confirms Non-binding Term Sheet To Acquire GSK's Certain Assets In Egypt, Tunisia (RTTNews)
22.01.21	GSK: ViiV Healthcare Gets FDA Approval For HIV Treatment Cabenuva - Quick Facts (RTTNews)
22.01.21	Immutep : GlaxoSmithKline Discontinues Phase II Study On Ulcerative Colitis (RTTNews)
12.01.21	Vir, GSK In Deal With NHS-Supported AGILE To Evaluate VIR-7832 In Early Treatment Of COVID-19 (RTTNews)
11.01.21	Eligo, GSK Sign Deal To Advance Eligobiotics For Treatment/prevention Of Acne Vulgaris (RTTNews)
29.12.20	Vectura Says GlaxoSmithKline Not To Seek Appeal For Re-hearing In Ongoing Ellipta Litigation (RTTNews)
21.12.20	Ligand Collaborates With GSK To Target Neurological Disorder; To Receive Up To $161 Mln Payment (RTTNews)
21.12.20	GSK: ViiV Healthcare's Vocabria Gets EU Approval To Be Used With Janssen's Rekambys And Edurant (RTTNews)
21.12.20	Sosei Collaborates With GSK On Immune Disorders Of Digestive System; Eligible To Receive Up $481 Mln (RTTNews)
17.12.20	GSK: FDA Approves BENLYSTA For Adult Patients With Active Lupus Nephritis In U.S. (RTTNews)
17.12.20	Surface Oncology Inks SRF813 Licensing Deal With GSK For $85 Mln Upfront - Quick Facts (RTTNews)
11.12.20	Sanofi, GSK Delay COVID-19 Vaccine Program Due To Low Immune Response In Elderly People (RTTNews)
12.11.20	Medicago, GSK Start Phase 2/3 Trials Of Adjuvanted COVID-19 Vaccine Candidate (RTTNews)
09.11.20	GSK: ViiV Healthcare Reports Superior Efficacy Of Cabotegravir For HIV Prevention In Women (RTTNews)
03.11.20	GSK Sets New Environmental Sustainability Goals - Quick Facts (RTTNews)
28.10.20	GlaxoSmithKline Q3 Pretax Profit Declines - Quick Facts (RTTNews)
28.10.20	Sanofi, GSK Intend To Supply 200 Mln Doses Of COVID-19 Vaccine To COVAX Facility (RTTNews)
27.10.20	ANAB, GSK Amend Agreement, BSGM Plunges As COVID-19 Trial Flops, CATB Craters, MRTX Abuzz (RTTNews)
16.10.20	GSK Says Viiv Healthcare Gets Positive CHMP Opinion For Long-acting HIV Regimen (RTTNews)
07.10.20	AXGT Reports Parkinson's Trial Data, CRBP Plunges As Cystic Fibrosis Study Fails, GMDA On Track (RTTNews)
06.10.20	GSK, AZN 1st To Use NVDA's Supercomputer, IOVA To Delay BLA Filing, YMAB Plunges, GLYC On Watch (RTTNews)
28.09.20	FDA Approves GlaxoSmithKline's Nucala To Treat Rare Blood Disorders (RTTNews)
18.09.20	Europe Signs Deal With Sanofi, GSK To Secure Up To 300 Mln COVID-19 Vaccine Doses (RTTNews)
10.09.20	AMPE Says Ampion Improves COVID-19 Symptoms, AMYT At Ease, ITCI Impresses With Depression Trial Data (RTTNews)
03.09.20	Sanofi, GSK Begin Phase 1/2 Clinical Trial For Adjuvanted COVID-19 Vaccine Candidate - Quick Facts (RTTNews)
01.09.20	ACST's CaPre Misses Goal Again, AIMT Snapped Up By Nestle, CRMD To Face FDA In Feb, VIR & COVID-19 (RTTNews)
31.08.20	Vir And Glaxo Start Phase 2/3 Trial For COVID-19 Antibody Treatment (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft

10.02.22

CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat

09.02.22

GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	535.20	0.79 %	K V
Sonova Hldg	306.90	0.76 %	K V
Roche Hldg G	252.60	0.48 %	K V
Kuehne+Nagel Int	209.40	0.38 %	K V
Alcon	77.84	0.28 %	K V
ABB	49.28	-0.52 %	K V
UBS Group	27.60	-0.58 %	K V
CieFinRichemont	121.45	-0.74 %	K V
Sika	226.80	-0.79 %	K V
Logitech Intl	70.68	-1.81 %	K V

Nachrichten zu GlaxoSmithKline plc (GSK) (ADRS)

Aktien Top/Flop

GlaxoSmithKline Peer Group Nachrichten

Meistgelesene Nachrichten